Abstract
There are concerns that biologic treatments or immunomodulation may negatively influence anastomotic healing. This study investigates the relationship between these treatments and anastomotic complications after surgery for Crohn's disease.
| Original language | English |
|---|---|
| Journal | Scandinavian Journal of Gastroenterology |
| Volume | 47 |
| Issue number | 6 |
| Pages (from-to) | 662-8 |
| Number of pages | 7 |
| ISSN | 0036-5521 |
| DOIs | |
| Publication status | Published - 2012 |
Keywords
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Anastomosis, Surgical
- Anastomotic Leak
- Anti-Inflammatory Agents
- Antibodies, Monoclonal
- Antibodies, Monoclonal, Humanized
- Child
- Colon
- Crohn Disease
- Female
- Glucocorticoids
- Humans
- Immunoglobulin Fab Fragments
- Immunosuppressive Agents
- Intestine, Small
- Intraabdominal Infections
- Logistic Models
- Male
- Middle Aged
- Multivariate Analysis
- Polyethylene Glycols
- Postoperative Complications
- Prednisolone
- Retrospective Studies
- Risk Factors
- Surgical Wound Dehiscence
- Young Adult
Fingerprint
Dive into the research topics of 'Biologic treatment or immunomodulation is not associated with postoperative anastomotic complications in abdominal surgery for Crohn's disease'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS